We are live on ! Find out more
CCM

Cadian Capital Management Portfolio holdings

AUM $821M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-14.36%
3 Year Est. Return
+4.6%
5 Year Est. Return
+8.64%
10 Year Est. Return
+282.79%
AUM
$1.38B
AUM Growth
-$332M
Cap. Flow
-$328M
Cap. Flow %
-23.8%
Top 10 Hldgs %
80.56%
Holding
58
New
2
Increased
6
Reduced
8
Closed
27

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$69.3M
2
HUBS icon
HubSpot
HUBS
+$50.1M
3
VRNS icon
Varonis Systems
VRNS
+$43.1M
4
PEGA icon
Pegasystems
PEGA
+$39.8M
5
DDOG icon
Datadog
DDOG
+$29.9M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$96.2M
2
PCOR icon
Procore
PCOR
+$83.7M
3
BKNG icon
Booking.com
BKNG
+$78.2M
4
PANW icon
Palo Alto Networks
PANW
+$69.2M
5
COUP
Coupa Software Incorporated
COUP
+$36.3M

Sector Composition

Rank Sector Weight
1 Technology 62.33%
2 Communication Services 19.89%
3 Consumer Discretionary 12.47%
4 Financials 4.79%
5 Healthcare 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPCA.WS
51
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
– –
-200,000
Closed -$14K
WPCB.WS
52
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
– –
-200,000
Closed -$12K
ASZ
53
DELISTED
Austerlitz Acquisition Corporation II
ASZ
– –
-2,325,000
Closed -$22.8M
NSTC.WS
54
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
– –
-250,000
Closed -$12K
ACII.WS
55
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
– –
-100,000
Closed -$5K
ASZ.WS
56
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
– –
-581,250
Closed -$78K
AUS.WS
57
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
– –
-250,000
Closed -$25K
AILE
58
DELISTED
iLearningEngines, Inc. Common Stock
AILE
– –
-500,000
Closed -$4.91M
1 2
3

Similar funds

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
DI
DUMAC Inc Durham, North Carolina $820M AUM
VT
Volterra Technologies New York $823M AUM 28.93% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $819M AUM 24.75% 1-Year Est. Return
MA
MJP Associates Farmington, Connecticut $824M AUM 14.86% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
SCM
Sirios Capital Management Boston, Massachusetts $825M AUM 50.18% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return

Cadian Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Cadian Capital Management held 58 positions worth $1.38B, down 19% from $1.71B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Cadian Capital Management withdrew a net $328M in Q4 2022, closing 27 positions and reducing 8 holdings. Its most notable exit was Blueprint Medicines, an estimated $96.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 59% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Cadian Capital Management opened a new position in Datadog worth $28.2M.

  • Cadian Capital Management's largest Q4 2022 buy was Datadog: 383,000 shares worth $28.2M.
  • Cadian Capital Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $69.3M increase.
  • Cadian Capital Management's biggest Q4 2022 reduction was Procore, cutting an estimated $83.7M.
  • Cadian Capital Management fully exited Blueprint Medicines in Q4 2022, selling an estimated $96.2M.
  • Cadian Capital Management's ten largest holdings make up 81% of its $1.38B portfolio in Q4 2022.
  • Cadian Capital Management opened 2 new positions and closed 27 in Q4 2022.
  • Cadian Capital Management's portfolio value fell 19% quarter-over-quarter to $1.38B.

Based on Cadian Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.